| Single domain antibodies: promising experimental and therapeutic tools in infection and immunity J Wesolowski, V Alzogaray, J Reyelt, M Unger, K Juarez, M Urrutia, ... Medical microbiology and immunology 198, 157-174, 2009 | 764 | 2009 |
| B lymphocytes are essential for the initiation of T cell-mediated autoimmune diabetes: analysis of a new" speed congenic" stock of NOD. Ig mu null mice. DV Serreze, HD Chapman, DS Varnum, MS Hanson, PC Reifsnyder, ... The Journal of experimental medicine 184 (5), 2049-2053, 1996 | 716 | 1996 |
| Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice. MJ Rapoport, A Jaramillo, D Zipris, AH Lazarus, DV Serreze, EH Leiter, ... The Journal of experimental medicine 178 (1), 87-99, 1993 | 621 | 1993 |
| B lymphocytes are critical antigen-presenting cells for the initiation of T cell-mediated autoimmune diabetes in nonobese diabetic mice DV Serreze, SA Fleming, HD Chapman, SD Richard, EH Leiter, RM Tisch The Journal of Immunology 161 (8), 3912-3918, 1998 | 569 | 1998 |
| Defects in limb, craniofacial, and thymic development in Jagged2 mutant mice R Jiang, Y Lan, HD Chapman, C Shawber, CR Norton, DV Serreze, ... Genes & development 12 (7), 1046-1057, 1998 | 538 | 1998 |
| Identification of the β cell antigen targeted by a prevalent population of pathogenic CD8+ T cells in autoimmune diabetes SM Lieberman, AM Evans, B Han, T Takaki, Y Vinnitskaya, JA Caldwell, ... Proceedings of the National Academy of Sciences 100 (14), 8384-8388, 2003 | 475 | 2003 |
| Interleukin-2 gene variation impairs regulatory T cell function and causes autoimmunity J Yamanouchi, D Rainbow, P Serra, S Howlett, K Hunter, VES Garner, ... Nature genetics 39 (3), 329-337, 2007 | 474 | 2007 |
| Major Histocompatibility Complex Class I-Deficient NOD-B2mnull Mice are Diabetes and Insulitis Resistant DV Serreze, EH Leiter, GJ Christianson, D Greiner, DC Roopenian Diabetes 43 (3), 505-509, 1994 | 406 | 1994 |
| TRPV1+ sensory neurons control β cell stress and islet inflammation in autoimmune diabetes R Razavi, Y Chan, FN Afifiyan, XJ Liu, X Wan, J Yantha, H Tsui, L Tang, ... Cell 127 (6), 1123-1135, 2006 | 403 | 2006 |
| Three recessive loci required for insulin-dependent diabetes in nonobese diabetic mice M Prochazka, EH Leiter, DV Serreze, DL Coleman Science 237 (4812), 286-289, 1987 | 394 | 1987 |
| Defects in the differentiation and function of antigen presenting cells in NOD/Lt mice. DV Serreze, HR Gaskins, EH Leiter Journal of immunology (Baltimore, Md.: 1950) 150 (6), 2534-2543, 1993 | 314 | 1993 |
| Defective activation of T suppressor cell function in nonobese diabetic mice. Potential relation to cytokine deficiencies. DV Serreze, EH Leiter Journal of immunology (Baltimore, Md.: 1950) 140 (11), 3801-3807, 1988 | 260 | 1988 |
| Acceleration of type 1 diabetes by a coxsackievirus infection requires a preexisting critical mass of autoreactive T-cells in pancreatic islets. DV Serreze, EW Ottendorfer, TM Ellis, CJ Gauntt, MA Atkinson Diabetes 49 (5), 708-711, 2000 | 253 | 2000 |
| Immunostimulation circumvents diabetes in NODLt mice DV Serreze, K Hamaguchi, EH Leiter Journal of autoimmunity 2 (6), 759-776, 1989 | 237 | 1989 |
| Hematopoietic stem-cell defects underlying abnormal macrophage development and maturation in NOD/Lt mice: defective regulation of cytokine receptors and protein kinase C. DV Serreze, JW Gaedeke, EH Leiter Proceedings of the National Academy of Sciences 90 (20), 9625-9629, 1993 | 232 | 1993 |
| Mouse models for the study of autoimmune type 1 diabetes: a NOD to similarities and differences to human disease JP Driver, DV Serreze, YG Chen Seminars in immunopathology 33, 67-87, 2011 | 230 | 2011 |
| Major histocompatibility complex class I-restricted T cells are required for all but the end stages of diabetes development in nonobese diabetic mice and use a prevalent T cell … TP DiLorenzo, RT Graser, T Ono, GJ Christianson, HD Chapman, ... Proceedings of the National Academy of Sciences 95 (21), 12538-12543, 1998 | 223 | 1998 |
| Th1 to Th2 cytokine shifts in nonobese diabetic mice: sometimes an outcome, rather than the cause, of diabetes resistance elicited by immunostimulation DV Serreze, HD Chapman, CM Post, EA Johnson, WL Suarez-Pinzon, ... The Journal of Immunology 166 (2), 1352-1359, 2001 | 215 | 2001 |
| NOR/Lt mice: MHC-matched diabetes-resistant control strain for NOD mice M Prochazka, DV Serreze, WN Frankel, EH Leiter Diabetes 41 (1), 98-106, 1992 | 211 | 1992 |
| Induction of glutamic acid decarboxylase 65-specific Th2 cells and suppression of autoimmune diabetes at late stages of disease is epitope dependent R Tisch, B Wang, DV Serreze The Journal of Immunology 163 (3), 1178-1187, 1999 | 205 | 1999 |
